Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous system
Andrew S. Bell, Josephin Wagner, Daniel B. Rosoff, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105155-105155
Closed Access | Times Cited: 20

Showing 20 citing articles:

Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Julia Odum, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16288-16288
Open Access | Times Cited: 67
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
Xuhui Bao, Yongjun Liang, Hanman Chang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
The relationship between statin therapy and adipocytokine/inflammatory mediators in dyslipidemic nondiabetic patients: A comparative study
Hany Akeel Al-Hussaniy, Ahmed Hamza Al-Shammari, Hayder Naji Sameer, et al.
Pharmacia (2023) Vol. 70, Iss. 3, pp. 581-585
Open Access | Times Cited: 17
Drug development advances in human genetics‐based targets
X. Zhang, Wenjun Yu, Yan Li, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 8
PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injury
Josephin Wagner, Lauren M. Park, Partha Mukhopadhyay, et al.
Brain Behavior and Immunity (2024) Vol. 119, pp. 494-506
Open Access | Times Cited: 6
Hypercholesterolemia and the Increased Risk of Vascular Dementia: a Cholesterol Perspective
Guojiao Shang, Qi Shao, Kai Lv, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 8, pp. 435-449
Closed Access | Times Cited: 6
The potential role of PCSK9 inhibitors in heart transplant patients: a case series
Mohammad Al Tamimi, Abeer Bakhsh, Sahar AlAmro, et al.
Journal of Cardiology & Current Research (2025) Vol. 18, Iss. 1, pp. 6-10
Open Access
Assessing the Impact of PCSK9 and HMGCR Inhibition on Liver Function: Drug-Target Mendelian Randomization Analyses in Four Ancestries
Daniel B. Rosoff, Andrew S. Bell, Josephin Wagner, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 17, Iss. 1, pp. 29-40
Open Access | Times Cited: 8
Effects of sodium arsenite exposure on behavior, ultrastructure and gene expression of brain in adult zebrafish (Danio rerio)
Hao Ma, Wenjing Yang, Yang Li, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 273, pp. 116107-116107
Open Access | Times Cited: 3
The Intersection of Cerebral Cholesterol Metabolism and Alzheimer's Disease: Mechanisms and Therapeutic Prospects
Licheng Liu, Junyi Liang, Yanhong Liu, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30523-e30523
Open Access | Times Cited: 2
Targeting PCSK9 as a key player in lipid metabolism: exploiting the therapeutic and biosensing potential of aptamers
Maryam Mahjoubin‐Tehran, Samaneh Rezaei, Raúl D. Santos, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
The Emerging Role of PCSK9 in the Pathogenesis of Alzheimer’s Disease: A Possible Target for the Disease Treatment
Gabriella Testa, Serena Giannelli, Erica Staurenghi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13637-13637
Open Access | Times Cited: 2
PCSK9 inhibitor protects against ischemic cerebral injury by attenuating inflammation via the GPNMB/CD44 pathway
Yaling Zheng, Tianrui Zhu, Gang Li, et al.
International Immunopharmacology (2023) Vol. 126, pp. 111195-111195
Open Access | Times Cited: 6
E3 ubiquitin ligase MARCH1 reduces inflammation and pyroptosis in cerebral ischemia-reperfusion injury via PCSK9 downregulation
Hongmei Guo, Wanli Li, Zhi‐gang Yang, et al.
Mammalian Genome (2024) Vol. 35, Iss. 3, pp. 346-361
Closed Access | Times Cited: 1
Function of proprotein convertase subtilisin/kexin type 9 and its role in central nervous system diseases: An update on clinical evidence
Xiaobin Zhu, Y.-M. Xu, Liucheng Li, et al.
Drug Development Research (2023) Vol. 85, Iss. 1
Closed Access | Times Cited: 2
Association of proprotein convertase subtilisin/kexin type 9 protein and oxidative stress indicators in women with preeclampsia: A case-control study
Anahita Abbasifard, Shohreh Alimohammadi, Ebrahim Abbasi Oshaghi, et al.
International Journal of Reproductive BioMedicine (IJRM) (2023)
Open Access | Times Cited: 2
The Synergistic Trio of Metabolic Master Regulators Sustaining a Vicious Circle of Pathological Processes in Post-Traumatic Stress Disorder
М. V. Kondashevskaya, К. А. Artemyeva, Л.М. Михалева
Journal of Evolutionary Biochemistry and Physiology (2024) Vol. 60, Iss. 3, pp. 988-1002
Open Access
PCSK9 in extrahepatic tissues: What can we expect from its inhibition?
Angela Pirillo, Lâle Tokgözoğlu, Alberico L. Catapano
European Atherosclerosis Journal (2023) Vol. 2, Iss. 2, pp. 35-43
Open Access | Times Cited: 1
Transcriptome Profiling of Phenylalanine-Treated Human Neuronal Model: Spotlight on Neurite Impairment and Synaptic Connectivity
Sara Stankovic, Andrijana Lazic, Marina Parezanovic, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10019-10019
Open Access
Synergic Trio of Metabolic Regulators Supporting the Vicious Circle of Pathological Processes in Post-Traumatic Stress Disorder
М. V. Kondashevskaya, К. А. Artemyeva, Л.М. Михалева
Российский физиологический журнал им  И  М  Сеченова (2024) Vol. 110, Iss. 5, pp. 704-722
Closed Access
Page 1

Scroll to top